Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
8,511,704
-
Share change
-
-37,518
-
Total reported value
-
$40,004,259
-
Price per share
-
$4.70
-
Number of holders
-
28
-
Value change
-
-$70,124
-
Number of buys
-
21
-
Number of sells
-
7
Institutional Holders of Summit Therapeutics Inc. - COM (SMMT) as of Q4 2020
As of 31 Dec 2020,
Summit Therapeutics Inc. - COM (SMMT) was held by
28 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,511,704 shares.
The largest 10 holders included
Polar Capital Holdings Plc, BlackRock Inc., JPMORGAN CHASE & CO, BAILLIE GIFFORD & CO, MORGAN STANLEY, RENAISSANCE TECHNOLOGIES LLC, ExodusPoint Capital Management, LP, UBS Group AG, WELLS FARGO & COMPANY/MN, and CAPSTONE INVESTMENT ADVISORS, LLC.
This page lists
28
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.